COVID-19 and hypertension in pregnancy: An analysis of clinical outcomes and sFlt-1 / PlGF biomarkers in vaccinated pregnant women

IF 2.5 4区医学 Q2 OBSTETRICS & GYNECOLOGY

Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health Pub Date : 2024-08-01 DOI:10.1016/j.preghy.2024.01.099

Maria Laura Costa do Nascimento , Guilherme de Moraes Nobrega , Jose Paulo Siqueira Guida , Luciana Pietro , Isabella Ally Vasconcelos Silva , Sarah Luiza Dariva , Renato Teixeira Souza , Jose Guilherme Cecatti

引用次数: 0

查看原文本刊更多论文

COVID-19 与妊娠高血压：分析接种疫苗孕妇的临床结果和 sFlt-1 / PlGF 生物标志物

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health OBSTETRICS & GYNECOLOGYPERIPHERAL VASCULAR-PERIPHERAL VASCULAR DISEASE

CiteScore

4.90

自引率

0.00%

发文量

127

期刊介绍： Pregnancy Hypertension: An International Journal of Women''s Cardiovascular Health aims to stimulate research in the field of hypertension in pregnancy, disseminate the useful results of such research, and advance education in the field. We publish articles pertaining to human and animal blood pressure during gestation, hypertension during gestation including physiology of circulatory control, pathophysiology, methodology, therapy or any other material relevant to the relationship between elevated blood pressure and pregnancy. The subtitle reflects the wider aspects of studying hypertension in pregnancy thus we also publish articles on in utero programming, nutrition, long term effects of hypertension in pregnancy on cardiovascular health and other research that helps our understanding of the etiology or consequences of hypertension in pregnancy. Case reports are not published unless of exceptional/outstanding importance to the field.